| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ec38905d57b9fda6d35ea26e720f958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d1750b578ca9a780678f6b9b9c8b87d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate |
2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fca6c3d09fdbf1518bea716bd55208bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc98617e19092045075813dd18de01f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_569b35ef91c5902321e9b4e1834cc38d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce9b72a9baa7139140afda8131f8474 |
| publicationDate |
2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014194500-A1 |
| titleOfInvention |
Methods For Treating of SARS |
| abstract |
Provided is a method of treating SARS in mammals. The method includes administering a therapeutically effective amount of at least one composition selected from the group consisting of myricetin, scutellarein and a pharmaceutically acceptable salt thereof to a mammal in need of treatment of SARS diseases to suppress the activities of SARS coronavirus helicase. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021175295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021243756-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023040733-A1 |
| priorityDate |
2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |